ホーム > 藤澤 康弘/ Fujisawa, Yasuhiro
藤澤 康弘
ALUMNI
2025年7月現在、筑波大学が主たる所属機関ではありません
Fujisawa, Yasuhiro
オープンアクセス版の論文は「つくばリポジトリ」で読むことができます。
-
141.
Bilateral metachronous cutaneous apocrine carcinoma with reduced PTEN expression.
Tatsuya Ogawa; Yosuke Ishitsuka; Yasuhiro Fujisawa; Hiroshi Maruyama (+3 著者) Manabu Fujimoto
European journal of dermatology : EJD 28: 372 (2018) Semantic Scholar
-
142.
Neurofibromatosis type 1-associated serious haemorrhagic events successfully treated with steroid pulse therapy.
Tatsuya Ogawa; Yosuke Ishitsuka; Sae Inoue; Yasuhiro FujisawaManabu Fujimoto
European journal of dermatology : EJD 28: 382 (2018) Semantic Scholar
-
143.
Reply: Lymph stasis promotes tumor growth.
Yoshiyuki Nakamura; Yasuhiro Fujisawa; Naoko Okiyama; Rei Watanabe (+3 著者) Hideaki Tahara
Journal of dermatological science 90: 367 (2018) Semantic Scholar
-
144.
Assessment of the methods used to detect HER2-positive advanced extramammary Paget's disease.
Ikuko Hirai; Keiji Tanese; Yoshio Nakamura; Atsushi Otsuka (+8 著者) Takeru Funakoshi
Medical oncology (Northwood, London, England) 35: 92 (2018) Semantic Scholar
-
145.
Surgical damage to the lymphatic system promotes tumor growth via impaired adaptive immune response.
Yoshiyuki Nakamura; Yasuhiro Fujisawa; Naoko Okiyama; Rei Watanabe (+3 著者) Manabu Fujimoto
Journal of dermatological science 90: 46 (2018) Semantic Scholar
-
146.
Serum levels of soluble CD163 and CXCL5 may be predictive markers for immune-related adverse events in patients with advanced melanoma treated with nivolumab: a pilot study.
Taku Fujimura; Yota Sato; Kayo Tanita; Yumi Kambayashi (+15 著者) Setsuya Aiba
Oncotarget 9: 15542 (2018) Semantic Scholar
-
147.
Third-line pembrolizumab-induced immune-related interstitial pneumonitis after ipilimumab and nivolumab failure.
Kazumasa Oya; Yoshiyuki Nakamura; Yasuhiro Fujisawa; Ruriko Endo (+5 著者) Manabu Fujimoto
European journal of dermatology : EJD 28: 129 (2018) Semantic Scholar
-
148.
Serum Level of Soluble CD163 May Be a Predictive Marker of the Effectiveness of Nivolumab in Patients With Advanced Cutaneous Melanoma.
Taku Fujimura; Yota Sato; Kayo Tanita; Yumi Kambayashi (+17 著者) Setsuya Aiba
Frontiers in oncology 8: 530 (2018) Semantic Scholar
-
149.
Cutaneous Angiosarcoma: The Possibility of New Treatment Options Especially for Patients with Large Primary Tumor.
Yasuhiro Fujisawa; Koji Yoshino; Taku Fujimura; Yoshiyuki Nakamura (+3 著者) Manabu Fujimoto
Frontiers in oncology 8: 46 (2018) Semantic Scholar
-
150.
Tumor-Associated Macrophages: Therapeutic Targets for Skin Cancer.
Taku Fujimura; Yumi Kambayashi; Yasuhiro Fujisawa; Takanori HidakaSetsuya Aiba
Frontiers in oncology 8: 3 (2018) Semantic Scholar
-
151.
Retrospective study of advanced melanoma patients treated with ipilimumab after nivolumab: Analysis of 60 Japanese patients.
Yasuhiro Fujisawa; Koji Yoshino; Atsushi Otsuka; Takeru Funakoshi (+12 著者) Yuki Yamamoto
Journal of dermatological science 89: 60 (2018) Semantic Scholar
-
152.
Clear cell sarcoma of the scalp: A case report.
Tatsuya Ogawa; Hiroshi Maruyama; Ryota Tanaka; Yasuhiro FujisawaManabu Fujimoto
The Journal of dermatology 44: e276-e277 (2017) Semantic Scholar
-
153.
Fluctuations in routine blood count might signal severe immune-related adverse events in melanoma patients treated with nivolumab.
Yasuhiro Fujisawa; Koji Yoshino; Atsushi Otsuka; Takeru Funakoshi (+12 著者) Shigeto Matsushita
Journal of dermatological science 88: 225 (2017) Semantic Scholar
-
154.
Pyoderma gangrenosum and underlying diseases in Japanese patients: A regional long-term study.
Sae Inoue; Jun-Ichi Furuta; Yasuhiro Fujisawa; Saori Onizawa (+9 著者) Manabu Fujimoto
The Journal of dermatology 44: 1281 (2017) Semantic Scholar
-
155.
Polymyositis induced by PD-1 blockade in a patient in hepatitis B remission.
Tatsuya Ogawa; Yosuke Ishitsuka; Hanako Koguchi-Yoshioka; Ryota Tanaka (+3 著者) Manabu Fujimoto
Journal of the neurological sciences 381: 22 (2017) Semantic Scholar
-
156.
The rate of facial nerve dysfunction and time to recovery after intraparotid and extraparotid facial nerve exposure and protection in head and neck cutaneous tumor surgery.
Yasuhiro Nakamura; Yukiko Teramoto; Yuri Asami; Taichi Imamura (+6 著者) Akifumi Yamamoto
International journal of clinical oncology 22: 843 (2017) Semantic Scholar
-
157.
Behandlung eines kutanen Plattenepithelkarzinoms mit intraarterieller Radiochemotherapie.
Kana Shibao; Yasuhiro Fujisawa; Yoshiyuki Nakamura; Yasuhiro Nakamura (+4 著者) Manabu Fujimoto
Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG 15: 724 (2017) Semantic Scholar
-
158.
Cutaneous squamous cell carcinoma treated with preoperative intraarterial chemoradiation therapy.
Kana Shibao; Yasuhiro Fujisawa; Yoshiyuki Nakamura; Yasuhiro Nakamura (+4 著者) Manabu Fujimoto
Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG 15: 724 (2017) Semantic Scholar
-
159.
Cutaneous surgery under local anesthesia in very elderly patients 90 years of age and older is as safe as in elderly patients ranging in age from 75 to 80 years old.
Taichi Imamura; Yasuhiro Nakamura; Ryota Tanaka; Yukiko Teramoto (+4 著者) Akifumi Yamamoto
International journal of dermatology 56: 681 (2017) Semantic Scholar
-
160.
Cytokine biomarkers to predict antitumor responses to nivolumab suggested in a phase 2 study for advanced melanoma.
Naoya Yamazaki; Yoshio Kiyohara; Hisashi Uhara; Hajime Iizuka (+9 著者) Hideaki Tahara
Cancer science 108: 1022 (2017) Semantic Scholar
書籍等出版物情報はまだありません。
講演・口頭発表情報はまだありません。
知財情報はまだありません。
1,661 total views
この研究者の他の情報源
ORCID
この研究者の情報を共有
